Editorial
Published on 10 Dec 2024
Editorial: Transplantation and cellular therapy in lymphomas and plasma cell disorders
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1527836
- 1,252 views
Type at least 3 characters
2,074 articles
articles
Original Research
Published on 09 Dec 2024
DL-ICE as a bridge to allogeneic transplantation in relapsed/refractory PTCL: survival outcomes and prognostic factors
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1461268
- 2,164 views
Original Research
Published on 09 Dec 2024
Efficacy and safety of hypomethylating agents in the treatment of AML/MDS patients relapsed post allogenetic hematopoietic stem cell transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1465334
- 2,249 views
- 1 citation
Case Report
Published on 05 Dec 2024
Clonally unrelated HL-type RS manifested as hemophagocytic syndrome: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1472560
- 1,780 views
Clinical Trial
Published on 05 Dec 2024
A 16-week progressive exercise training intervention in treatment-naïve chronic lymphocytic leukaemia: a randomised-controlled pilot study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1472551
- 5,448 views
- 1 citation
Case Report
Published on 05 Dec 2024
Case report: HSV lymphadenitis in immunocompromised patient with CLL
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1401208
- 2,643 views
- 1 citation
Case Report
Published on 05 Dec 2024
Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1491100
- 3,043 views
Case Report
Published on 05 Dec 2024
Case report: Paraganglioma masquerading as angiosarcoma: diagnostic‐dilemma in vascular tumors
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1462956
- 1,303 views
- 1 citation
Review
Published on 04 Dec 2024
Updates in novel immunotherapeutic strategies for relapsed/refractory AML
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1374963
- 6,395 views
- 6 citations
Case Report
Published on 03 Dec 2024
Castleman disease variant of POEMS syndrome without M protein: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1449945
- 2,972 views
- 1 citation
Case Report
Published on 27 Nov 2024
Sustained yet non-curative response to lenalidomide in relapsed angioimmunoblastic T-cell lymphoma with acquired chidamide resistance: a case report with 10-year follow-up, genetic insights and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1471090
- 3,279 views
- 1 citation
Case Report
Published on 26 Nov 2024
Case report: Successful use of ruxolitinib to treat interstitial pneumonia as an unusual primary presentation in primary myelofibrosis—two birds with one stone
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1475036
- 2,087 views
Review
Published on 26 Nov 2024
Recommendations for the effective use of T-cell–redirecting therapies: a Canadian consensus statement
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1446995
- 7,737 views
- 2 citations
Original Research
Published on 25 Nov 2024
Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1485039
- 5,403 views
- 3 citations
Original Research
Published on 21 Nov 2024
Hematopoietic stem cell transplantation to improve prognosis in aggressive monomorphic epitheliotropic intestinal T-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1388623
- 3,511 views
- 6 citations
Original Research
Published on 21 Nov 2024
The characteristics of patients with multiple myeloma surviving over 10 years
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1490630
- 3,464 views
- 2 citations
Systematic Review
Published on 20 Nov 2024
Ponatinib vs. asciminib in post–second-generation tyrosine kinase inhibitor therapy for chronic-phase chronic myeloid leukemia: a matching-adjusted indirect comparison
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1455378
- 7,660 views
- 4 citations
Case Report
Published on 14 Nov 2024
Hemangiopericytoma following allogeneic hematopoietic stem cell transplantation in a patient with primary plasma cell leukemia: the first case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1467237
- 1,462 views
Mini Review
Published on 04 Nov 2024
Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1490202
- 5,899 views
- 3 citations
Case Report
Published on 31 Oct 2024
TIPIC syndrome in a patient following sorafenib treatment for acute myeloid leukemia: a rare case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1484256
- 1,858 views
- 1 citation
Original Research
Published on 31 Oct 2024
End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1436587
- 2,352 views
- 1 citation
Review
Published on 31 Oct 2024
Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1447001
- 6,464 views
- 5 citations
Original Research
Published on 31 Oct 2024
The identification and correction of pseudohypercalcemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1441851
- 3,761 views
- 1 citation
Brief Research Report
Published on 24 Oct 2024
Complex karyotypes in hematologic disorders: a 12-year single-center study from Lebanon
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1480793
- 2,126 views
- 2 citations